FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD)

被引：9
|
作者：
Wu, Yinlian
Kumar, Rahul
Huang, Jiaofeng
Wang, Mingfang
Zhu, Yueyong
Lin, Su
机构：
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 74卷 / 01期
关键词：
Metabolic associated fatty liver disease; Nonalcoholic fatty liver disease; FIB-4;
D O I：
10.1016/j.jhep.2020.06.040
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：247 / 248
页数：3
相关论文
共 50 条
  • [1] Reply to: "FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD)"
    Tsochatzis, Emmanuel A.
    Srivastava, Ankur
    Rosenberg, William
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (01) : 248 - 249
  • [2] DO WE NEED A NEW CUT-OFF FOR FIB-4 IN THE METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE ERA?
    Ahn, Sang Bong
    Park, Huiyul
    Yoon, Eileen
    Jun, Dae Won
    An, Ji Hyun
    Sohn, Joo Hyun
    Kim, Mimi
    Kang, Bo-Kyeong
    Lee, Chul-Min
    [J]. HEPATOLOGY, 2021, 74 : 1005A - 1005A
  • [3] Do we need a new cut-off for FIB-4 in the metabolic dysfunction-associated fatty liver disease era?
    Park, Huiyul
    Yoon, Eileen L.
    Cho, Seon
    Nah, Eun-Hee
    Jun, Dae Won
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 (03) : 725 - 726
  • [4] FIB-4 cut-off of 1.3 may be inappropriate in a primary care referral pathway for patients with non-alcoholic fatty liver disease
    Shah, Samir
    Dhami-Shah, Hiteshi
    Kamble, Swati
    Shukla, Akash
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 216 - 217
  • [5] Letter: changes in FIB-4 cut-off points for viral hepatitis
    Kayadibi, H.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (07) : 1007 - 1008
  • [6] Re-determining the cut-off points of FIB-4 for patients monoinfected with chronic hepatitis B virus infection
    Kayadibi, Huseyin
    Yasar, Bulent
    Ozkara, Selvinaz
    Demirpek, Ugur
    Uyanik, Metin
    Sertoglu, Erdim
    Ozcelik, Fatih
    Gonen, Can
    Aksaray, Sebahat
    [J]. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2017, 42 (01): : 51 - 57
  • [7] Letter: changes in FIB-4 cut-off points for viral hepatitis - authors' reply
    Surana, P.
    Takyar, V.
    Koh, C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (07) : 1008 - 1009
  • [8] Comparison of diagnostic performance between FIB-4 and NFS in metabolic-associated fatty liver disease era
    Park, Huiyul
    Yoon, Eileen L.
    Kim, Mimi
    Lee, Jonghyun
    Kim, Jung-Hwan
    Cho, Seon
    Jun, Dae Won
    Nah, Eun-Hee
    [J]. HEPATOLOGY RESEARCH, 2022, 52 (03) : 247 - 254
  • [9] Comparison of diagnostic performance between FIB-4 and NFS in metabolic-associated fatty liver disease era
    Jun, Dae Won
    Yoon, Eileen
    Ahn, Sang Bong
    Park, Huiyul
    Lee, Hyo Young
    Oh, Hyunwoo
    Sohn, Joo Hyun
    Kang, Bo-Kyeong
    Kim, Mi Mi
    Lee, Chul-min
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S438 - S438
  • [10] Reply to: "FIB-4 cut off of 1.3 may be inappropriate in a primary care referral pathway for patients with non-alcoholic fatty liver disease"
    Tsochatzis, Emmanuel A.
    Srivastava, Ankur
    Rosenberg, William
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 217 - 218
12345